94 results
Page 2 of 5
8-K
EX-1.1
atspvy h2
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm
424B5
u7hup2q59
14 Sep 22
Prospectus supplement for primary offering
4:12pm
424B5
9zats40mf8 mjaggurd
13 Sep 22
Prospectus supplement for primary offering
5:19pm
8-K
EX-99.1
mtbdr f0vmjs1echovmu
13 Sep 22
POINT Biopharma Announces Proposed Public Offering of Common Stock
4:12pm
424B3
d1xldrzua
11 Jul 22
Prospectus supplement
4:32pm
POS AM
oihb0vwfom
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
S-3
EX-1.2
vnewx zptdj
1 Jul 22
Shelf registration
4:13pm
S-3
1928t
1 Jul 22
Shelf registration
4:13pm
424B3
o7dvepoj8b2in kukn
13 May 22
Prospectus supplement
8:18am
424B3
EX-31.2
brd bf3edslhp88t
13 May 22
Prospectus supplement
8:18am
424B3
EX-31.1
onpqfjv05mcv6yypd
13 May 22
Prospectus supplement
8:18am
DEF 14A
liuth1m3pcgcq0 sae
28 Apr 22
Definitive proxy
8:36am
424B3
pztt3fx3 wtb5omzjk
31 Mar 22
Prospectus supplement
11:42am
POS AM
kiun6
25 Mar 22
Prospectus update (post-effective amendment)
8:41am